US EditionChanges in Federal Vaccine Funding Won't Affect Availability in Tucson This Fall
UNITED STATES, AUG 8 – Health Secretary Robert F. Kennedy Jr. redirected $500 million from mRNA vaccine projects to alternative platforms citing safety concerns, sparking expert criticism over pandemic preparedness.
- On Aug. 5, HHS Secretary Robert F. Kennedy Jr. announced halting funding for 22 mRNA vaccine projects worth nearly $500 million at BARDA.
- After reviewing the science and consulting top U.S. experts, Kennedy claimed 2022 meta-analyses showed mRNA vaccines offered no net benefit and posed increased risks.
- Dr. Jennifer Nuzzo, Brown University Pandemic Center director, warned retreating from mRNA technology undermines bioattack deterrence and innovation, citing Rasmussen's point that 'Viruses mutate when they replicate, and they replicate when they spread through a population of people.'
- Vaccine and preparedness experts warned that the cancellation could derail future Operation Warp Speed efforts and leave the United States at the back of the line in a crisis.
- Despite the funding cuts, Bannon vowed his WarRoom will support banning pharma ads and flooding the public with data, as Kennedy approved new mRNA vaccines since last month.
45 Articles
45 Articles
Once ‘Very Pro-Vaccine,’ Trump Shrugs Off Kennedy’s mRNA Cuts
During the early days of the coronavirus pandemic in the spring of 2020, President Trump was warned by medical officials that the development of a vaccine that could turn the tide against Covid could be over a year away. For Mr. Trump, that timeline was not good enough. He demanded a faster program. The creation of that program, Operation Warp Speed, led to lifesaving vaccines that contained messenger RNA, or mRNA, a synthetic form of a genetic …
RFK Jr. is attacking the very science that saved millions
HHS Secretary Robert F. Kennedy Jr.’s decision to cut $500 million in federal funding for mRNA vaccine development is based on a fundamental misunderstanding of vaccinology that could cost lives in future pandemics.
Focuses on mRNA technology • Claims high risks
Coverage Details
Bias Distribution
- 36% of the sources lean Left, 36% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
